V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214902 | 20155403 | 1.72 | 87 | null | 2018-06-30 | 2018-09-13 | EOX | N | null | EOX | 100778382 |
| 20214907 | 20155404 | 1.72 | 49.9 | Palliative (P) | 2019-03-04 | 2019-03-17 | EOX | 02 | N | TRIAL | 100571351 |
| 20214909 | 20155405 | 1.59 | 68.2 | Palliative (P) | 2018-06-30 | 2018-07-21 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100769305 |
| 20214910 | 20155406 | 1.83 | null | Palliative (P) | null | 2022-01-15 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100687275 |
| 20214912 | 20155407 | 1.59 | 100.6 | Palliative (P) | null | 2017-04-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100294619 |
| 20214914 | 20155408 | null | 61.2 | Palliative (P) | 2019-08-21 | 2019-08-21 | EOX | N | N | EOX | 101577670 |
| 20214919 | 20155409 | 1.77 | 80.3 | Palliative (P) | 2019-11-24 | 2019-12-23 | Trial Unspecified | 02 | N | TRIAL | 101227601 |
| 20214921 | 20155410 | 1.58 | 60.3 | Palliative (P) | 2017-04-28 | 2021-04-21 | Sorafenib | 02 | N | SORAFENIB | 101732550 |
| 20214927 | 20155411 | 1.6 | 75.9 | Palliative (P) | 2017-03-13 | 2017-03-13 | EOX | N | N | EOX | 101454050 |
| 20214929 | 20155412 | 1.72 | 114 | Palliative (P) | 2018-08-25 | 2018-08-25 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100749383 |
| 20214939 | 20155413 | 1.57 | 55 | Palliative (P) | 2019-07-07 | 2019-07-07 | EOX | N | N | EOX | 101357472 |
| 20214940 | 20155414 | 1.71 | 93 | Neo-adjuvant (N) | 2016-11-12 | 2017-02-17 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 100136660 |
| 20214942 | 20155415 | 1.76 | 75.9 | Neo-adjuvant (N) | 2021-02-13 | 2021-02-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101583772 |
| 20214944 | 20155416 | 1.67 | 73.5 | Palliative (P) | 2020-09-27 | 2020-10-18 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101257816 |
| 20214945 | 20155417 | 1.64 | 57.05 | Curative (C) | 2016-10-09 | 2016-10-09 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101395902 |
| 20214946 | 20155418 | 1.57 | 96.2 | Neo-adjuvant (N) | null | 2019-11-25 | Trial Unspecified | 02 | Y | TRIAL | 101338200 |
| 20214947 | 20155419 | null | 0 | Adjuvant (A) | 2018-04-25 | 2018-04-29 | EOX | 1 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101136537 |
| 20214952 | 20155420 | 1.64 | 0 | Palliative (P) | 2019-07-19 | 2019-07-19 | EOX | N | N | OXALIPLATIN + RALTITREXED | 100014991 |
| 20214955 | 20155421 | 1.7 | 76.7 | Palliative (P) | 2017-11-18 | 2018-11-29 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101504337 |
| 20214956 | 20155422 | 1.58 | 81 | Neo-adjuvant (N) | 2017-08-15 | 2017-10-10 | Sorafenib | Y | N | SORAFENIB | 101417284 |
| 20214957 | 20155423 | null | 64.8 | Palliative (P) | 2020-10-30 | 2020-11-20 | Sorafenib | 02 | N | SORAFENIB | 100333603 |
| 20214959 | 20155424 | 1.72 | 39 | Curative (C) | 2019-08-10 | 2019-08-13 | Trial Unspecified | 02 | Y | TRIAL | 101358801 |
| 20214966 | 20155425 | 1.57 | 68.1 | null | 2020-02-10 | 2020-02-23 | EOX | N | null | EOX | 101333253 |
| 20214971 | 20155426 | 1.79 | 73.4 | Palliative (P) | 2021-02-11 | 2021-03-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101187335 |
| 20214972 | 20155427 | 1.71 | 46.2 | Neo-adjuvant (N) | null | 2017-07-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101139540 |
| 20214976 | 20155428 | 1.84 | 83.8 | Palliative (P) | 2020-08-20 | 2020-08-29 | Sorafenib | N | N | SORAFENIB | 100942694 |
| 20214978 | 20155429 | 1.61 | 78.3 | Curative (C) | 2017-12-27 | 2017-12-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 100077899 |
| 20214982 | 20155430 | 1.67 | 74.7 | Palliative (P) | 2016-09-23 | 2016-11-16 | EOX | 02 | N | SORAFENIB | 100293986 |
| 20214984 | 20155431 | 1.53 | 15.6 | null | 2021-12-08 | 2021-12-22 | Trial Unspecified | N | null | EOX | 101056184 |
| 20214985 | 20155432 | 1.6 | 83.8 | Curative (C) | 2018-12-17 | 2019-01-14 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 101837086 |
| 20214987 | 20155433 | null | 65 | null | 2017-03-07 | 2017-03-20 | Sorafenib | 02 | null | SORAFENIB | 101329346 |
| 20214995 | 20155434 | 1.63 | 115.7 | Palliative (P) | null | 2018-05-30 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101342111 |
| 20214996 | 20155435 | 1.74 | 74.3 | null | 2019-08-29 | 2019-09-19 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101827991 |
| 20214999 | 20155436 | 1.6 | 0 | null | 2021-03-14 | 2021-04-09 | EOX | 99 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101838997 |
| 20215000 | 20155437 | 1.67 | 91.2 | null | 2018-10-14 | 2018-10-19 | Capecitabine 35days + RT | N | null | EOX | 101028630 |
| 20215003 | 20155438 | 1.69 | 77.7 | Palliative (P) | 2017-03-07 | 2017-03-09 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101564000 |
| 20215005 | 20155439 | 1.91 | 111.05 | Palliative (P) | null | 2016-09-26 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101757701 |
| 20215007 | 20155440 | 1.64 | 88.9 | Curative (C) | 2016-09-08 | 2017-05-10 | Trial Unspecified | null | Y | TRIAL | 100540303 |
| 20215008 | 20155441 | 1.84 | 79.85 | Palliative (P) | 2020-02-21 | 2020-06-28 | Sorafenib | 02 | N | SORAFENIB | 101363561 |
| 20215011 | 20155442 | 1.65 | 70.6 | Palliative (P) | 2020-02-12 | 2020-02-13 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100497948 |
| 20215014 | 20155443 | 1.83 | 59 | Palliative (P) | null | 2018-06-06 | Sorafenib | N | N | SORAFENIB | 100530573 |
| 20215017 | 20155444 | 1.54 | 102.1 | Palliative (P) | 2017-09-05 | 2017-09-21 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101634349 |
| 20215019 | 20155445 | 1.92 | 55 | Palliative (P) | 2019-05-03 | 2019-05-06 | Sorafenib | 2 | N | SORAFENIB | 100060602 |
| 20215020 | 20155446 | 1.78 | 57 | Palliative (P) | 2020-10-05 | 2020-11-02 | EOX | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101439653 |
| 20215022 | 20155447 | 1.62 | 90.1 | Adjuvant (A) | 2020-09-25 | 2020-09-29 | EOX | null | N | CETUXIMAB + IRINOTECAN + MDG | 100813707 |
| 20215024 | 20155448 | 1.68 | 88.1 | Palliative (P) | 2017-05-28 | 2017-06-15 | EOX | N | N | EOX | 100061798 |
| 20215025 | 20155449 | 1.75 | 64.4 | null | null | 2018-08-22 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100042753 |
| 20215036 | 20155450 | 1.89 | null | null | 2017-03-11 | 2017-04-05 | Capecitabine 35days + RT | N | null | CAPECITABINE + RT | 101450021 |
| 20215040 | 20155451 | 1.7 | 109 | Palliative (P) | 2022-04-25 | 2022-04-27 | EOX | 02 | N | EOX | 100095257 |
| 20215047 | 20155452 | 1.72 | 80 | Palliative (P) | null | null | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100699655 |